Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

BACKGROUND: Whole exome sequencing and RNA sequencing (WES/RNASeq) should now be implemented in the clinical practice in order to increase access to optimal care for cancer patients. Providing results to Tumour Boards in a relevant time frame—that is, compatible with the clinical pathway—is crucial....

Descripción completa

Detalles Bibliográficos
Autores principales: Auzanneau, Céline, Bacq, Delphine, Bellera, Carine, Blons, Hélène, Boland, Anne, Boucheix, Marlène, Bourdon, Aurélien, Chollet, Emmanuelle, Chomienne, Christine, Deleuze, Jean-François, Delmas, Christelle, Dinart, Derek, Espérou, Hélène, Geillon, Flore, Geneste, Damien, Italiano, Antoine, Jean, Delphine, Khalifa, Emmanuel, Laizet, Yec'han, Laurent-Puig, Pierre, Lethimonnier, Franck, Lévy-Marchal, Claire, Lucchesi, Carlo, Malle, Carine, Mancini, Pierre, Mathoulin-Pélissier, Simone, Meyer, Vincent, Marie-Ange, Palomares, Perkins, Géraldine, Sellan-Albert, Sabrina, Soubeyran, Isabelle, Wallet, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383956/
https://www.ncbi.nlm.nih.gov/pubmed/32713836
http://dx.doi.org/10.1136/esmoopen-2020-000744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383956/
https://www.ncbi.nlm.nih.gov/pubmed/32713836
http://dx.doi.org/10.1136/esmoopen-2020-000744

Ejemplares similares